PHBI (Pharmagreen Biotech) Common Stock: $0.46 Mil (As of Jun. 2023)


What is Pharmagreen Biotech Common Stock?

Pharmagreen Biotech PHBI Common Stock is $0.46 Mil as of Jun. 2023.

Pharmagreen Biotech's quarterly common stock stayed the same from Dec. 2022 ($0.46 Mil) to Mar. 2023 ($0.46 Mil) but then increased from Mar. 2023 ($0.46 Mil) to Jun. 2023 ($0.46 Mil).

Pharmagreen Biotech's annual common stock increased from Sep. 2020 ($0.10 Mil) to Sep. 2021 ($0.38 Mil) and increased from Sep. 2021 ($0.38 Mil) to Sep. 2022 ($0.44 Mil).

Pharmagreen Biotech Common Stock Historical Data

* Premium members only.

The historical data trend for Pharmagreen Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagreen Biotech Common Stock Chart

Pharmagreen Biotech Annual Data
Trend Apr08 Apr09 Sep18 Sep19 Sep20 Sep21 Sep22
Common Stock
Get a 7-Day Free Trial 0.07 0.08 0.10 0.38 0.44

Pharmagreen Biotech Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.44 0.46 0.46 0.46

Pharmagreen Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.46 Mil mean?
Pharmagreen Biotech (PHBI) has a Common Stock of $0.46 Mil as of Jun. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Common Stock too high?
Pharmagreen Biotech's current Common Stock is $0.46 Mil.
How does Pharmagreen Biotech's Common Stock compare to DVLP and CSTF?
Pharmagreen Biotech's Common Stock of $0.46 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Pharmagreen Biotech and its competitors. Pharmagreen Biotech's current Common Stock is $0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Common Stock of $0.46 Mil. The current Common Stock is $0.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Common Stock is $0.46 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagreen Biotech Business Description

Address 112 North Curry Street, Carson, NV, USA, 89703
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.